21st May 2024

PHARMANOVIA PARTNERS WITH ECHO THERAPEUTICS FOR PROMOTIONAL ACTIVITIES IN AUSTRALIA

For immediate release, 20TH May, 2024 Pharmanovia, the lifecycle management company, has today announced that it...

More information
16th May 2024

Closed Loop Medicine and Pharmanovia commence study for their first precision medicine combination therapeutic

PRESS RELEASE: For global business and medical media only 16 May 2024 Closed Loop Medicine and...

More information
6th February 2024

Pharmanovia appoints new regional manager – Spain, Portugal and France

For business and pharma trade media only BASILDON, UK, 30 January 2024 Pharmanovia, a global pharmaceutical...

More information
10th November 2023

Pharmanovia CEO, James Burt appointed Chair of Medicines for Europe’s Value Added Medicines (VAM) sector group

PRESS RELEASE (business and pharma trade only) FOR IMMEDIATE RELEASE, Basildon, 9 November 2023 Pharmanovia, a...

More information
1st November 2023

Pharmanovia joins IRDiRC task force to publish drug repurposing guidebook aimed at improving care for people living with rare disease

PRESS RELEASE (Pharma trade media only) London, 1 November 2023 THE GUIDEBOOK HAS BEEN PUBLISHED IN...

More information
18th September 2023

Pharmanovia acquires global central nervous system (CNS) portfolio from Sanofi

FOR TRADE, BUSINESS AND MEDICAL MEDIA ONLY Basildon, UK, 18 September 2023 Pharmanovia, a global pharmaceutical...

More information
7th June 2023

Global pharmaceutical leader sets sight on sustainable future for the sector by setting challenging SBTI Net Zero target

Pharmanovia unveils results in new Sustainability Report and pledges commitment to new environmental and sustainability targets...

More information
1st June 2023

PHARMANOVIA ANNOUNCES NEW CHIEF FINANCIAL OFFICER (CFO)

BASILDON, UK, 1 June 2023 Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises,...

More information
30th May 2023

Pharmanovia enters new chemical entity licensing agreement with Stealth BioTherapeutics to market and further develop a potential novel treatment for Barth Syndrome

PRESS RELEASE: FOR BUSINESS AND TRADE MEDIA ONLY BASILDON, UK, 30 MAY 2023 Pharmanovia, a global...

More information

For all media enquiries please contact: communications@pharmanovia.com